http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109776434-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 |
| filingDate | 2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109776434-B |
| titleOfInvention | 3-benzyl-6-acylamino-2, 4- (1H,3H) -quinazoline diketone derivative and synthesis method and application thereof |
| abstract | The invention relates to a 3-benzyl-6-acylamino-2, 4- (1H,3H) -quinazoline diketone derivative and a synthesis method and application thereof, belongs to the technical field of medicaments, and relates to a general formula (I), R 1 ，R 2 ，R 3 Are different substituents. The invention discloses the structures and the synthesis methods of the compounds, the inhibitory activity of acetylcholinesterase and the inhibitory activity of phosphodiesterase 5, and the compounds can be further developed into medicaments for treating Alzheimer's disease. |
| priorityDate | 2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.